Skip to main content
Steven Warach, MD, Neurology, Austin, TX, Dell Seton Medical Center at the University of Texas

StevenWarachMDPhD

Neurology • Austin, TX

Vascular Neurology

Professor of Neurology. Dell Medical School. University of Texas at Austin.

Join to view full profile

Dr. Warach is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Warach's full profile

Already have an account?

Summary

  • Steven Warach, MD, PhD is a vascular neurologist and neuroscientist in Austin, TX. He is currently Professor of Neurology at Dell Medical School at The University of Texas at Austin and Stroke Director for Dell Med and Ascension Texas’ network of hospitals, including Dell Seton Medical Center at the University of Texas, Ascension Seton Medical Center Austin, Ascension Seton Williamson, and Ascension Seton Hays. He has been in practice for over 30 years.

    Warach earned his Ph.D. in Psychology-Neuroscience from Michigan State University and M.D. from Harvard Medical School, where he completed his neurology residency. Warach established stroke clinical, research, and training programs for Beth Israel Hospital - Harvard, the National Institute of Neurological Disorders and Stroke’s Division of Intramural Research, and Ascension – Dell Medical School.

    Warach is known for his seminal contributions in magnetic resonance imaging of stroke. He introduced into routine clinical practice and validated diffusion-weighted MRI, which revolutionized the diagnosis of acute ischemic stroke. He pioneered the diffusion-perfusion mismatch to image the ischemic penumbra in stroke patients and championed the use of penumbral imaging in clinical trials to select patients with the optimal target for acute stroke therapies, which paved the way for breakthroughs trials of effective thrombolysis and endovascular thrombectomy at late time windows. His recent work has been influential in leading the adoption of tenecteplase as a standard of care for acute stroke thrombolysis across the US. Warach has received numerous awards and recognitions for his work, most recently the David G. Sherman Lecture Award of the American Stroke Association/American Heart Association, which recognizes lifetime contributions to the investigation, management, mentorship, and community service in the stroke field.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1989 - 1993
  • Newton-Wellesley Hospital
    Newton-Wellesley HospitalInternship, Internal Medicine, 1988 - 1989
  • Harvard Medical School
    Harvard Medical SchoolClass of 1988

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2012 - 2026
  • MD State Medical License
    MD State Medical License 1999 - 2013
  • DC State Medical License
    DC State Medical License 2001 - 2013
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Vascular Neurology

Awards, Honors, & Recognition

  • David G. Sherman Lecture Award American Stroke Association/American Heart Association, 2024

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Stroke Thrombolysis with Tenecteplase to Reduce Emergency Department Spread of Coronavirus Disease 2019 and Shortages of Alteplase  
    Steven J Warach, Jeffrey L Saver, JAMA Neurology

Lectures

  • DWI and PI Are the Ideal Tools for Selecting Patients for Any Recanalization Therapy in Any Time Window 
    Austin, TX - 2/13/2014

Authored Content

  • Stroke Thrombolysis with Tenecteplase to Reduce Emergency Department Spread of Coronavirus Disease 2019 and Shortages of AlteplaseJuly 2020

Press Mentions

  • Your Health: Austin Stroke Study Creates More Treatments for Larger Strokes
    Your Health: Austin Stroke Study Creates More Treatments for Larger StrokesMarch 3rd, 2023
  • New Drug Found by UT Study to Outperform Standard Stroke Medication
    New Drug Found by UT Study to Outperform Standard Stroke MedicationOctober 9th, 2022
  • Transition to Newer Clot-Busting Drug Improves Patient Outcomes, Lowers Cost in Treating Ischemic Stroke
    Transition to Newer Clot-Busting Drug Improves Patient Outcomes, Lowers Cost in Treating Ischemic StrokeSeptember 23rd, 2022
  • Join now to see all

Grant Support

  • Eval, Pathogenesis, Outcome Of Subjects With Or Suspected Traumatic Brain InjuryNational Institute Of Neurological Disorders And Stroke2010–2011
  • Novel Insights Into Cerebral Ischemic Pathophysiology In HumansNational Institute Of Neurological Disorders And Stroke2009–2011
  • Developing Innovative Stroke Trial DesignsNational Institute Of Neurological Disorders And Stroke2009–2011
  • Clinical, Imaging, And Experimental Core Support Of Acute Stroke ResearchNational Institute Of Neurological Disorders And Stroke2009–2011
  • Clinical Trial Protocols For Acute Ischemic StrokeNational Institute Of Neurological Disorders And Stroke2009–2011
  • Novel Insights Into Cerebral Ischemic Pathophysiology In HumansNational Institute Of Neurological Disorders And Stroke2007–2008
  • Developing Innovative Stroke Trial DesignsNational Institute Of Neurological Disorders And Stroke2007–2008
  • Clinical, Imaging, And Experimental Core Support Of Acute Stroke ResearchNational Institute Of Neurological Disorders And Stroke2007–2008
  • Clinical Trial Protocols For Acute Ischemic StrokeNational Institute Of Neurological Disorders And Stroke2007–2008
  • Improving The Diagnosis Of Acute StrokeNational Institute Of Neurological Disorders And Stroke2007
  • Section On Stroke Diagnostics And TherapeuticsNational Institute Of Neurological Disorders And Stroke2004–2005
  • Acute Stroke Diagnostics And TherapeuticsNational Institute Of Neurological Disorders And Stroke1999–2003
  • Basic Fibroblast Growth Factor In Acute Ischemic StrokeNational Center For Research Resources1997–1999
  • Diffusion/Perfusion MRI Of Ischemic PenumbraNational Institute Of Neurological Disorders And Stroke1995–1998
  • Efficacy And Safety Of Eliprodil In Patients With Acute Ischemic StrokeNational Center For Research Resources1997
  • Reversible Ischemic Injury Identified By Diffusion MRINational Institute Of Neurological Disorders And Stroke1993–1997

Professional Memberships

Hospital Affiliations

Dr. Steven Warach, Dr. Steven Warach, MD, Dr. S Warach